Minimally Invasive Surgical Instruments Market: By Product Type (Auxiliary Devices, Cutter Instruments, Electrosurgical Devices, Guiding Devices, Handheld Instruments, Inflation Devices, Monitoring & Visualization Devices), By Application (Cardiothoracic Surgery, Cosmetic/Bariatric Surgery, Gastrointestinal Surgery, Gynecological Surgery, Orthopedic Surgery, Urological Surgery, Vascular Surgery Others), By End User (Hospitals, Clinics,Ambulatory Surgical Centres (ASC) and Geography  

Minimally Invasive Surgical Instruments Market size was valued at USD 14,858.0 million in 2023 and is projected to reach USD 23,089.2 million by 2030 and poised to grow at a 6.5% from 2024-2030. The minimally invasive surgical instruments market is driven by the increasing prevalence of chronic diseases, technological advancements, the growing aging population, and the rise in surgical volumes. Chronic diseases such as cancer, heart disease, and obesity are on the rise globally. This is leading to a growing demand for minimally invasive surgeries, which can offer patients several benefits, such as shorter hospital stays. The development of new technologies is constantly improving the capabilities of minimally invasive surgical instruments. For example, robotic surgery systems are becoming more sophisticated and are being used for a wider range of procedures.

The global population is aging, and as people age, they are more likely to require surgery. Minimally invasive surgeries are often a better option for older patients, as they can help to reduce the risks associated with surgery. The overall volume of surgeries performed worldwide is increasing. This is due to several factors, such as the aging population and the growing availability of new surgical procedures. Development of new and innovative instruments, expansion into emerging markets, and increasing focus on outpatient surgery are the opportunities and miniaturization of instruments, convergence of technologies, and use of artificial intelligence are the trends in the minimally invasive surgical instruments market. Despite the positive outlook the minimally invasive surgical instruments market constraints will hinder the market growth through the high cost of instruments, reimbursement challenges, and lack of skilled surgeons.

Minimally Invasive Surgical Instruments Market Key Developments:

• In December 2022, the international healthcare corporation Abbott revealed the introduction of its new transcatheter aortic valve implantation (TAVI) system, Navitor™. This cutting-edge, minimally invasive device is now accessible to patients in India suffering from severe aortic stenosis who face a high or very high risk from traditional surgery.
• In March 2021, Ethicon, a part of the Johnson & Johnson Medical Devices Companies, announced the global launch of the ECHELON+ Stapler with GST Reloads1. This new powered surgical stapler was designed to enhance staple line security and reduce complications by providing more uniform tissue compression and better staple formation, even in challenging clinical situations.